News updates: nano-based diagnostics for COVID-19

Written by The Nanomed Zone, Lucy Chard, Editor

Nanotechnology is being used at surface-level for the development of COVID-19 tests. The SARS-CoV-2 spike protein provides a target for visualization and nano-based technologies are able to identify this protein in a more rapid and accurate way than current diagnostics being used. This article shows a timeline of the efforts of different research and biotechnology groups in making these tests available as soon as possible.   Evaluation of serological tests to detect SARS-CoV-2 A team of scientists from Institut Pasteur, the CNRS, Inserm and Université de Paris (all France) have undertaken a study to evaluate the current tests for diagnosing...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!